4-aminophenyl alpha-d-mannopyranoside has been researched along with Glioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, J; Guo, J; Li, RJ; Lou, JN; Lu, WL; Men, Y; Shang, DW; Tian, W; Wen, H; Yang, TY; Ying, X; Zhang, LR; Zhang, Q; Zhang, Y | 1 |
1 other study(ies) available for 4-aminophenyl alpha-d-mannopyranoside and Glioma
Article | Year |
---|---|
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Topics: Aniline Compounds; Animals; Antibiotics, Antineoplastic; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Chemistry, Pharmaceutical; Daunorubicin; Drug Carriers; Flow Cytometry; Glioma; Liposomes; Male; Mannosides; Mice; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Time Factors; Transferrin | 2010 |